Suppr超能文献

格雷夫斯病促甲状腺素受体抗体(TSAb)的免疫化学特征:有限异质性的证据

Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity.

作者信息

Zakarija M

出版信息

J Clin Lab Immunol. 1983 Feb;10(2):77-85.

PMID:6133001
Abstract

The thyroid-stimulating antibody (TSAb) of Graves' disease is an IgG; its immunochemical characteristics were analyzed using an increase in the concentration of cyclic AMP in the human thyroid slice in vitro for its assay. IgG from serum known to contain TSAb in high concentration was purified and H chains from this IgG were combined with Bence Jones k or lambda L chains or original L chains; reconstitution of IgG was confirmed by agar gel and immunoelectrophoresis. In studies with 6 sera there was no thyroid stimulation on testing such recombined molecules except for minimal activity in one instance of recombination of original H and L chains. In 8 other experiments TSAb-IgG containing only k or lambda L chain was isolated by affinity chromatography. In 7 instances thyroid-stimulating potency was entirely with IgG lambda, except for minor activity in IgGk in 3 of these studies; in the eighth preparation TSAb was predominantly in IgGk with minimal activity in IgG lambda that was assayed at a much higher concentration. By chromatography on Protein A Sepharose, IgG3 was obtained and it was found to contain no TSAb; activity was, however, recovered in the Protein A-retained fraction (i.e. IgG 1 + 2 + 4). With 3 preparations of TSAb-IgG lambda, subclasses 1 + 2 + 4, removal by affinity chromatography of subclass 4 led to full recovery of TSAb in subclasses 1 + 2. On subsequent removal of subclass 2, in two instances all activity was retained by subclass 1; in the third preparation some TSAb was not accounted for. These data, together with previous reports from this laboratory showing a relatively constant pI for TSAb-IgG on preparative isoelectric focusing, are compatible with its having restricted heterogeneity, instead of being polyclonal as described by others.

摘要

格雷夫斯病的促甲状腺素抗体(TSAb)是一种IgG;通过体外检测人甲状腺切片中环磷酸腺苷浓度的升高来分析其免疫化学特性以进行该抗体的测定。从已知含有高浓度TSAb的血清中纯化IgG,并将该IgG的重链与本斯·琼斯κ或λ轻链或原始轻链结合;通过琼脂凝胶和免疫电泳确认IgG的重构。在对6份血清的研究中,除了一次原始重链和轻链重组实例中有最小活性外,对这种重组分子进行检测时没有甲状腺刺激作用。在另外8个实验中,通过亲和层析分离出仅含有κ或λ轻链的TSAb-IgG。在7个实例中,甲状腺刺激活性完全存在于IgGλ中,在其中3项研究中IgGκ有轻微活性;在第八份制剂中,TSAb主要存在于IgGκ中,而在更高浓度下测定的IgGλ中活性最小。通过蛋白A琼脂糖凝胶层析获得了IgG3,发现其不含TSAb;然而,活性在蛋白A保留部分(即IgG 1 + 2 + 4)中恢复。对于3份TSAb-IgGλ制剂(亚类1 + 2 + 4),通过亲和层析去除亚类4导致亚类1 + 2中TSAb完全恢复。随后去除亚类2时,在两个实例中所有活性都保留在亚类1中;在第三份制剂中,一些TSAb无法解释。这些数据,连同本实验室以前的报告显示在制备性等电聚焦时TSAb-IgG的pI相对恒定一起,与其具有有限的异质性相符,而不是如其他人所描述的是多克隆的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验